aluates Reports

$ 0.0

Automative

Global Oseltamivir Intermediate Market Research Report 2025

Published Date: November 2025

Report Code: QYRE-Auto-39K19949

BUY CHAPTERS

Global Oseltamivir Intermediate Market Research Report 2025

Code: QYRE-Auto-39K19949

Report

November 2025

Pages:87

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Manus Aktteva Biopharma LLP

Apeloa Pharmaceutical

Yiling Pharmaceutical

Hangzhou HETA Pharm & Chem

Shanghai Neutan Pharmaceutical

Ningxia Yiming Biomedical Technology

Oseltamivir Intermediate Market Size

The global market for Oseltamivir Intermediate was valued at US$ 1092 million in the year 2024 and is projected to reach a revised size of US$ 1561 million by 2031, growing at a CAGR of 5.3% during the forecast period.

Oseltamivir Intermediate Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Oseltamivir Intermediate competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Oseltamivir intermediates refer to the key chemical raw material intermediates used in the synthesis of the antiviral drug oseltamivir. These typically include (3R,4R,5S)-4-acetamido-5-carbamoyl-3-(1-ethyleneoxy)-cyclohexenoic acid ethyl ester and (3R,4R,5S)-4-acetamido-5-carbamoyl-3-(1-hydroxyethyl)-cyclohexenoic acid ethyl ester. Production involves two routes: chemical synthesis and biocatalysis. The former is a mature process with lower costs, while the latter is environmentally friendly and produces higher purity. In 2024, global sales of oseltamivir intermediates were approximately 260 tons, with an average price of approximately US$420 per kilogram and a single-line production capacity of approximately 40 tons. Upstream companies are mainly pharmaceutical intermediate and fine chemical enterprises, providing raw materials such as amino acid derivatives, ester compounds, and catalysts. Downstream companies are mainly pharmaceutical raw material manufacturers and formulation companies, such as Roche, Kelun, and CSPC Pharmaceutical Group. The product gross profit margin is approximately 35%. In the product cost structure, raw materials account for approximately 55%, labor and energy for 20%, and equipment depreciation and management costs for approximately 25%. Classified by parameters, products can be categorized into industrial and pharmaceutical grades, chemically synthesized and biocatalytic types, and those with a purity ≥95% and ≥99%. On the demand side, downstream demand mainly comes from manufacturers of anti-influenza drug formulations, generic drug companies, and research institutions. Downstream customers include Roche, Pfizer, Chia Tai Tianqing Pharmaceutical Group, and Qilu Pharmaceutical. Regarding business opportunities, policy drivers include increased stockpiling of influenza prevention and treatment drugs by various countries; technological innovation is driving biocatalytic processes to replace traditional routes to improve yield and environmental performance; and changing consumer demands are reflected in the increasing long-term public demand for antiviral drugs and a growing market preference for high-purity raw materials.

North American market for Oseltamivir Intermediate is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Oseltamivir Intermediate is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Oseltamivir Intermediate include Manus Aktteva Biopharma LLP, Apeloa Pharmaceutical, Yiling Pharmaceutical, Hangzhou HETA Pharm & Chem, Shanghai Neutan Pharmaceutical, Ningxia Yiming Biomedical Technology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oseltamivir Intermediate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oseltamivir Intermediate.

The Oseltamivir Intermediate market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oseltamivir Intermediate market comprehensively. Regional market sizes, concerning products by Type, by Application, by Grade and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oseltamivir Intermediate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Grade and by regions.

Scope of Oseltamivir Intermediate Market Report

Report Metric	Details
Report Name	Oseltamivir Intermediate Market
Accounted market size in year	US$ 1092 million
Forecasted market size in 2031	US$ 1561 million
CAGR	5.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Content: ≥95.0% Content: ≥99.0%
Segment by Grade	Industrial Grade Pharmaceutical Grade
Segment by Synthesis Type	Chemical Synthesis Type Biocatalytic Type
Segment by Application	Chemical Industry Pharmaceutical And Scientific Research Others
Production by Region	North America Europe China Japan India Southeast Asia
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Manus Aktteva Biopharma LLP, Apeloa Pharmaceutical, Yiling Pharmaceutical, Hangzhou HETA Pharm & Chem, Shanghai Neutan Pharmaceutical, Ningxia Yiming Biomedical Technology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, by Grade etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oseltamivir Intermediate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Oseltamivir Intermediate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Oseltamivir Intermediate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

FAQ for this report

How fast is Oseltamivir Intermediate Market growing?

Ans: The Oseltamivir Intermediate Market witnessing a CAGR of 5.3% during the forecast period 2025-2031.

What is the Oseltamivir Intermediate Market size in 2031?

Ans: The Oseltamivir Intermediate Market size in 2031 will be US$ 1561 million.

Who are the main players in the Oseltamivir Intermediate Market report?

Ans: The main players in the Oseltamivir Intermediate Market are Manus Aktteva Biopharma LLP, Apeloa Pharmaceutical, Yiling Pharmaceutical, Hangzhou HETA Pharm & Chem, Shanghai Neutan Pharmaceutical, Ningxia Yiming Biomedical Technology

What are the Application segmentation covered in the Oseltamivir Intermediate Market report?

Ans: The Applications covered in the Oseltamivir Intermediate Market report are Chemical Industry, Pharmaceutical And Scientific Research, Others

What are the Type segmentation covered in the Oseltamivir Intermediate Market report?

Ans: The Types covered in the Oseltamivir Intermediate Market report are Chemical Synthesis Type, Biocatalytic Type

1 Oseltamivir Intermediate Market Overview

1.1 Product Definition

1.2 Oseltamivir Intermediate by Type

1.2.1 Global Oseltamivir Intermediate Market Value Growth Rate Analysis by Type: 2024 VS 2031

1.2.2 Content: ≥95.0%

1.2.3 Content: ≥99.0%

1.3 Oseltamivir Intermediate by Grade

1.3.1 Global Oseltamivir Intermediate Market Value Growth Rate Analysis by Grade: 2024 VS 2031

1.3.2 Industrial Grade

1.3.3 Pharmaceutical Grade

1.4 Oseltamivir Intermediate by Synthesis Type

1.4.1 Global Oseltamivir Intermediate Market Value Growth Rate Analysis by Synthesis Type: 2024 VS 2031

1.4.2 Chemical Synthesis Type

1.4.3 Biocatalytic Type

1.5 Oseltamivir Intermediate by Application

1.5.1 Global Oseltamivir Intermediate Market Value Growth Rate Analysis by Application: 2024 VS 2031

1.5.2 Chemical Industry

1.5.3 Pharmaceutical And Scientific Research

1.5.4 Others

1.6 Global Market Growth Prospects

1.6.1 Global Oseltamivir Intermediate Production Value Estimates and Forecasts (2020-2031)

1.6.2 Global Oseltamivir Intermediate Production Capacity Estimates and Forecasts (2020-2031)

1.6.3 Global Oseltamivir Intermediate Production Estimates and Forecasts (2020-2031)

1.6.4 Global Oseltamivir Intermediate Market Average Price Estimates and Forecasts (2020-2031)

1.7 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Oseltamivir Intermediate Production Market Share by Manufacturers (2020-2025)

2.2 Global Oseltamivir Intermediate Production Value Market Share by Manufacturers (2020-2025)

2.3 Global Key Players of Oseltamivir Intermediate, Industry Ranking, 2023 VS 2024

2.4 Global Oseltamivir Intermediate Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.5 Global Oseltamivir Intermediate Average Price by Manufacturers (2020-2025)

2.6 Global Key Manufacturers of Oseltamivir Intermediate, Manufacturing Base Distribution and Headquarters

2.7 Global Key Manufacturers of Oseltamivir Intermediate, Product Offered and Application

2.8 Global Key Manufacturers of Oseltamivir Intermediate, Date of Enter into This Industry

2.9 Oseltamivir Intermediate Market Competitive Situation and Trends

2.9.1 Oseltamivir Intermediate Market Concentration Rate

2.9.2 Global 5 and 10 Largest Oseltamivir Intermediate Players Market Share by Revenue

2.10 Mergers & Acquisitions, Expansion

3 Oseltamivir Intermediate Production by Region

3.1 Global Oseltamivir Intermediate Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.2 Global Oseltamivir Intermediate Production Value by Region (2020-2031)

3.2.1 Global Oseltamivir Intermediate Production Value by Region (2020-2025)

3.2.2 Global Forecasted Production Value of Oseltamivir Intermediate by Region (2026-2031)

3.3 Global Oseltamivir Intermediate Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.4 Global Oseltamivir Intermediate Production Volume by Region (2020-2031)

3.4.1 Global Oseltamivir Intermediate Production by Region (2020-2025)

3.4.2 Global Forecasted Production of Oseltamivir Intermediate by Region (2026-2031)

3.5 Global Oseltamivir Intermediate Market Price Analysis by Region (2020-2025)

3.6 Global Oseltamivir Intermediate Production and Value, Year-over-Year Growth

3.6.1 North America Oseltamivir Intermediate Production Value Estimates and Forecasts (2020-2031)

3.6.2 Europe Oseltamivir Intermediate Production Value Estimates and Forecasts (2020-2031)

3.6.3 China Oseltamivir Intermediate Production Value Estimates and Forecasts (2020-2031)

3.6.4 Japan Oseltamivir Intermediate Production Value Estimates and Forecasts (2020-2031)

3.6.5 India Oseltamivir Intermediate Production Value Estimates and Forecasts (2020-2031)

3.6.6 Southeast Asia Oseltamivir Intermediate Production Value Estimates and Forecasts (2020-2031)

4 Oseltamivir Intermediate Consumption by Region

4.1 Global Oseltamivir Intermediate Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

4.2 Global Oseltamivir Intermediate Consumption by Region (2020-2031)

4.2.1 Global Oseltamivir Intermediate Consumption by Region (2020-2025)

4.2.2 Global Oseltamivir Intermediate Forecasted Consumption by Region (2026-2031)

4.3 North America

4.3.1 North America Oseltamivir Intermediate Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.3.2 North America Oseltamivir Intermediate Consumption by Country (2020-2031)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Oseltamivir Intermediate Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.4.2 Europe Oseltamivir Intermediate Consumption by Country (2020-2031)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Oseltamivir Intermediate Consumption Growth Rate by Region: 2020 VS 2024 VS 2031

4.5.2 Asia Pacific Oseltamivir Intermediate Consumption by Region (2020-2031)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Oseltamivir Intermediate Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.6.2 Latin America, Middle East & Africa Oseltamivir Intermediate Consumption by Country (2020-2031)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global Oseltamivir Intermediate Production by Type (2020-2031)

5.1.1 Global Oseltamivir Intermediate Production by Type (2020-2025)

5.1.2 Global Oseltamivir Intermediate Production by Type (2026-2031)

5.1.3 Global Oseltamivir Intermediate Production Market Share by Type (2020-2031)

5.2 Global Oseltamivir Intermediate Production Value by Type (2020-2031)

5.2.1 Global Oseltamivir Intermediate Production Value by Type (2020-2025)

5.2.2 Global Oseltamivir Intermediate Production Value by Type (2026-2031)

5.2.3 Global Oseltamivir Intermediate Production Value Market Share by Type (2020-2031)

5.3 Global Oseltamivir Intermediate Price by Type (2020-2031)

6 Segment by Application

6.1 Global Oseltamivir Intermediate Production by Application (2020-2031)

6.1.1 Global Oseltamivir Intermediate Production by Application (2020-2025)

6.1.2 Global Oseltamivir Intermediate Production by Application (2026-2031)

6.1.3 Global Oseltamivir Intermediate Production Market Share by Application (2020-2031)

6.2 Global Oseltamivir Intermediate Production Value by Application (2020-2031)

6.2.1 Global Oseltamivir Intermediate Production Value by Application (2020-2025)

6.2.2 Global Oseltamivir Intermediate Production Value by Application (2026-2031)

6.2.3 Global Oseltamivir Intermediate Production Value Market Share by Application (2020-2031)

6.3 Global Oseltamivir Intermediate Price by Application (2020-2031)

7 Key Companies Profiled

7.1 Manus Aktteva Biopharma LLP

7.1.1 Manus Aktteva Biopharma LLP Oseltamivir Intermediate Company Information

7.1.2 Manus Aktteva Biopharma LLP Oseltamivir Intermediate Product Portfolio

7.1.3 Manus Aktteva Biopharma LLP Oseltamivir Intermediate Production, Value, Price and Gross Margin (2020-2025)

7.1.4 Manus Aktteva Biopharma LLP Main Business and Markets Served

7.1.5 Manus Aktteva Biopharma LLP Recent Developments/Updates

7.2 Apeloa Pharmaceutical

7.2.1 Apeloa Pharmaceutical Oseltamivir Intermediate Company Information

7.2.2 Apeloa Pharmaceutical Oseltamivir Intermediate Product Portfolio

7.2.3 Apeloa Pharmaceutical Oseltamivir Intermediate Production, Value, Price and Gross Margin (2020-2025)

7.2.4 Apeloa Pharmaceutical Main Business and Markets Served

7.2.5 Apeloa Pharmaceutical Recent Developments/Updates

7.3 Yiling Pharmaceutical

7.3.1 Yiling Pharmaceutical Oseltamivir Intermediate Company Information

7.3.2 Yiling Pharmaceutical Oseltamivir Intermediate Product Portfolio

7.3.3 Yiling Pharmaceutical Oseltamivir Intermediate Production, Value, Price and Gross Margin (2020-2025)

7.3.4 Yiling Pharmaceutical Main Business and Markets Served

7.3.5 Yiling Pharmaceutical Recent Developments/Updates

7.4 Hangzhou HETA Pharm & Chem

7.4.1 Hangzhou HETA Pharm & Chem Oseltamivir Intermediate Company Information

7.4.2 Hangzhou HETA Pharm & Chem Oseltamivir Intermediate Product Portfolio

7.4.3 Hangzhou HETA Pharm & Chem Oseltamivir Intermediate Production, Value, Price and Gross Margin (2020-2025)

7.4.4 Hangzhou HETA Pharm & Chem Main Business and Markets Served

7.4.5 Hangzhou HETA Pharm & Chem Recent Developments/Updates

7.5 Shanghai Neutan Pharmaceutical

7.5.1 Shanghai Neutan Pharmaceutical Oseltamivir Intermediate Company Information

7.5.2 Shanghai Neutan Pharmaceutical Oseltamivir Intermediate Product Portfolio

7.5.3 Shanghai Neutan Pharmaceutical Oseltamivir Intermediate Production, Value, Price and Gross Margin (2020-2025)

7.5.4 Shanghai Neutan Pharmaceutical Main Business and Markets Served

7.5.5 Shanghai Neutan Pharmaceutical Recent Developments/Updates

7.6 Ningxia Yiming Biomedical Technology

7.6.1 Ningxia Yiming Biomedical Technology Oseltamivir Intermediate Company Information

7.6.2 Ningxia Yiming Biomedical Technology Oseltamivir Intermediate Product Portfolio

7.6.3 Ningxia Yiming Biomedical Technology Oseltamivir Intermediate Production, Value, Price and Gross Margin (2020-2025)

7.6.4 Ningxia Yiming Biomedical Technology Main Business and Markets Served

7.6.5 Ningxia Yiming Biomedical Technology Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Oseltamivir Intermediate Industry Chain Analysis

8.2 Oseltamivir Intermediate Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Oseltamivir Intermediate Production Mode & Process Analysis

8.4 Oseltamivir Intermediate Sales and Marketing

8.4.1 Oseltamivir Intermediate Sales Channels

8.4.2 Oseltamivir Intermediate Distributors

8.5 Oseltamivir Intermediate Customer Analysis

9 Oseltamivir Intermediate Market Dynamics

9.1 Oseltamivir Intermediate Industry Trends

9.2 Oseltamivir Intermediate Market Drivers

9.3 Oseltamivir Intermediate Market Challenges

9.4 Oseltamivir Intermediate Market Restraints

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

FEATURED COMPANIES

Manus Aktteva Biopharma LLP

Apeloa Pharmaceutical

Yiling Pharmaceutical

Hangzhou HETA Pharm & Chem

Shanghai Neutan Pharmaceutical

Ningxia Yiming Biomedical Technology

List of Tables

Table 1. Global Oseltamivir Intermediate Market Value by Type, (US$ Million) & (2024 VS 2031)

Table 2. Global Oseltamivir Intermediate Market Value by Grade, (US$ Million) & (2024 VS 2031)

Table 3. Global Oseltamivir Intermediate Market Value by Synthesis Type, (US$ Million) & (2024 VS 2031)

Table 4. Global Oseltamivir Intermediate Market Value by Application, (US$ Million) & (2024 VS 2031)

Table 5. Global Oseltamivir Intermediate Production Capacity (Tons) by Manufacturers in 2024

Table 6. Global Oseltamivir Intermediate Production by Manufacturers (2020-2025) & (Tons)

Table 7. Global Oseltamivir Intermediate Production Market Share by Manufacturers (2020-2025)

Table 8. Global Oseltamivir Intermediate Production Value by Manufacturers (2020-2025) & (US$ Million)

Table 9. Global Oseltamivir Intermediate Production Value Share by Manufacturers (2020-2025)

Table 10. Global Key Players of Oseltamivir Intermediate, Industry Ranking, 2023 VS 2024

Table 11. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Oseltamivir Intermediate as of 2024)

Table 12. Global Market Oseltamivir Intermediate Average Price by Manufacturers (US$/kg) & (2020-2025)

Table 13. Global Key Manufacturers of Oseltamivir Intermediate, Manufacturing Base Distribution and Headquarters

Table 14. Global Key Manufacturers of Oseltamivir Intermediate, Product Offered and Application

Table 15. Global Key Manufacturers of Oseltamivir Intermediate, Date of Enter into This Industry

Table 16. Global Oseltamivir Intermediate Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 17. Mergers & Acquisitions, Expansion Plans

Table 18. Global Oseltamivir Intermediate Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 19. Global Oseltamivir Intermediate Production Value (US$ Million) by Region (2020-2025)

Table 20. Global Oseltamivir Intermediate Production Value Market Share by Region (2020-2025)

Table 21. Global Oseltamivir Intermediate Production Value (US$ Million) Forecast by Region (2026-2031)

Table 22. Global Oseltamivir Intermediate Production Value Market Share Forecast by Region (2026-2031)

Table 23. Global Oseltamivir Intermediate Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)

Table 24. Global Oseltamivir Intermediate Production (Tons) by Region (2020-2025)

Table 25. Global Oseltamivir Intermediate Production Market Share by Region (2020-2025)

Table 26. Global Oseltamivir Intermediate Production (Tons) Forecast by Region (2026-2031)

Table 27. Global Oseltamivir Intermediate Production Market Share Forecast by Region (2026-2031)

Table 28. Global Oseltamivir Intermediate Market Average Price (US$/kg) by Region (2020-2025)

Table 29. Global Oseltamivir Intermediate Market Average Price (US$/kg) by Region (2026-2031)

Table 30. Global Oseltamivir Intermediate Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)

Table 31. Global Oseltamivir Intermediate Consumption by Region (2020-2025) & (Tons)

Table 32. Global Oseltamivir Intermediate Consumption Market Share by Region (2020-2025)

Table 33. Global Oseltamivir Intermediate Forecasted Consumption by Region (2026-2031) & (Tons)

Table 34. Global Oseltamivir Intermediate Forecasted Consumption Market Share by Region (2026-2031)

Table 35. North America Oseltamivir Intermediate Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)

Table 36. North America Oseltamivir Intermediate Consumption by Country (2020-2025) & (Tons)

Table 37. North America Oseltamivir Intermediate Consumption by Country (2026-2031) & (Tons)

Table 38. Europe Oseltamivir Intermediate Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)

Table 39. Europe Oseltamivir Intermediate Consumption by Country (2020-2025) & (Tons)

Table 40. Europe Oseltamivir Intermediate Consumption by Country (2026-2031) & (Tons)

Table 41. Asia Pacific Oseltamivir Intermediate Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)

Table 42. Asia Pacific Oseltamivir Intermediate Consumption by Region (2020-2025) & (Tons)

Table 43. Asia Pacific Oseltamivir Intermediate Consumption by Region (2026-2031) & (Tons)

Table 44. Latin America, Middle East & Africa Oseltamivir Intermediate Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)

Table 45. Latin America, Middle East & Africa Oseltamivir Intermediate Consumption by Country (2020-2025) & (Tons)

Table 46. Latin America, Middle East & Africa Oseltamivir Intermediate Consumption by Country (2026-2031) & (Tons)

Table 47. Global Oseltamivir Intermediate Production (Tons) by Type (2020-2025)

Table 48. Global Oseltamivir Intermediate Production (Tons) by Type (2026-2031)

Table 49. Global Oseltamivir Intermediate Production Market Share by Type (2020-2025)

Table 50. Global Oseltamivir Intermediate Production Market Share by Type (2026-2031)

Table 51. Global Oseltamivir Intermediate Production Value (US$ Million) by Type (2020-2025)

Table 52. Global Oseltamivir Intermediate Production Value (US$ Million) by Type (2026-2031)

Table 53. Global Oseltamivir Intermediate Production Value Market Share by Type (2020-2025)

Table 54. Global Oseltamivir Intermediate Production Value Market Share by Type (2026-2031)

Table 55. Global Oseltamivir Intermediate Price (US$/kg) by Type (2020-2025)

Table 56. Global Oseltamivir Intermediate Price (US$/kg) by Type (2026-2031)

Table 57. Global Oseltamivir Intermediate Production (Tons) by Application (2020-2025)

Table 58. Global Oseltamivir Intermediate Production (Tons) by Application (2026-2031)

Table 59. Global Oseltamivir Intermediate Production Market Share by Application (2020-2025)

Table 60. Global Oseltamivir Intermediate Production Market Share by Application (2026-2031)

Table 61. Global Oseltamivir Intermediate Production Value (US$ Million) by Application (2020-2025)

Table 62. Global Oseltamivir Intermediate Production Value (US$ Million) by Application (2026-2031)

Table 63. Global Oseltamivir Intermediate Production Value Market Share by Application (2020-2025)

Table 64. Global Oseltamivir Intermediate Production Value Market Share by Application (2026-2031)

Table 65. Global Oseltamivir Intermediate Price (US$/kg) by Application (2020-2025)

Table 66. Global Oseltamivir Intermediate Price (US$/kg) by Application (2026-2031)

Table 67. Manus Aktteva Biopharma LLP Oseltamivir Intermediate Company Information

Table 68. Manus Aktteva Biopharma LLP Oseltamivir Intermediate Specification and Application

Table 69. Manus Aktteva Biopharma LLP Oseltamivir Intermediate Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 70. Manus Aktteva Biopharma LLP Main Business and Markets Served

Table 71. Manus Aktteva Biopharma LLP Recent Developments/Updates

Table 72. Apeloa Pharmaceutical Oseltamivir Intermediate Company Information

Table 73. Apeloa Pharmaceutical Oseltamivir Intermediate Specification and Application

Table 74. Apeloa Pharmaceutical Oseltamivir Intermediate Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 75. Apeloa Pharmaceutical Main Business and Markets Served

Table 76. Apeloa Pharmaceutical Recent Developments/Updates

Table 77. Yiling Pharmaceutical Oseltamivir Intermediate Company Information

Table 78. Yiling Pharmaceutical Oseltamivir Intermediate Specification and Application

Table 79. Yiling Pharmaceutical Oseltamivir Intermediate Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 80. Yiling Pharmaceutical Main Business and Markets Served

Table 81. Yiling Pharmaceutical Recent Developments/Updates

Table 82. Hangzhou HETA Pharm & Chem Oseltamivir Intermediate Company Information

Table 83. Hangzhou HETA Pharm & Chem Oseltamivir Intermediate Specification and Application

Table 84. Hangzhou HETA Pharm & Chem Oseltamivir Intermediate Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 85. Hangzhou HETA Pharm & Chem Main Business and Markets Served

Table 86. Hangzhou HETA Pharm & Chem Recent Developments/Updates

Table 87. Shanghai Neutan Pharmaceutical Oseltamivir Intermediate Company Information

Table 88. Shanghai Neutan Pharmaceutical Oseltamivir Intermediate Specification and Application

Table 89. Shanghai Neutan Pharmaceutical Oseltamivir Intermediate Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 90. Shanghai Neutan Pharmaceutical Main Business and Markets Served

Table 91. Shanghai Neutan Pharmaceutical Recent Developments/Updates

Table 92. Ningxia Yiming Biomedical Technology Oseltamivir Intermediate Company Information

Table 93. Ningxia Yiming Biomedical Technology Oseltamivir Intermediate Specification and Application

Table 94. Ningxia Yiming Biomedical Technology Oseltamivir Intermediate Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 95. Ningxia Yiming Biomedical Technology Main Business and Markets Served

Table 96. Ningxia Yiming Biomedical Technology Recent Developments/Updates

Table 97. Key Raw Materials Lists

Table 98. Raw Materials Key Suppliers Lists

Table 99. Oseltamivir Intermediate Distributors List

Table 100. Oseltamivir Intermediate Customers List

Table 101. Oseltamivir Intermediate Market Trends

Table 102. Oseltamivir Intermediate Market Drivers

Table 103. Oseltamivir Intermediate Market Challenges

Table 104. Oseltamivir Intermediate Market Restraints

Table 105. Research Programs/Design for This Report

Table 106. Key Data Information from Secondary Sources

Table 107. Key Data Information from Primary Sources

Table 108. Authors List of This Report

List of Figures

Figure 1. Product Picture of Oseltamivir Intermediate

Figure 2. Global Oseltamivir Intermediate Market Value by Type, (US$ Million) & (2020-2031)

Figure 3. Global Oseltamivir Intermediate Market Share by Type: 2024 VS 2031

Figure 4. Content: ≥95.0% Product Picture

Figure 5. Content: ≥99.0% Product Picture

Figure 6. Global Oseltamivir Intermediate Market Value by Grade, (US$ Million) & (2020-2031)

Figure 7. Global Oseltamivir Intermediate Market Share by Grade: 2024 VS 2031

Figure 8. Industrial Grade Product Picture

Figure 9. Pharmaceutical Grade Product Picture

Figure 10. Global Oseltamivir Intermediate Market Value by Synthesis Type, (US$ Million) & (2020-2031)

Figure 11. Global Oseltamivir Intermediate Market Share by Synthesis Type: 2024 VS 2031

Figure 12. Chemical Synthesis Type Product Picture

Figure 13. Biocatalytic Type Product Picture

Figure 14. Global Oseltamivir Intermediate Market Value by Application, (US$ Million) & (2020-2031)

Figure 15. Global Oseltamivir Intermediate Market Share by Application: 2024 VS 2031

Figure 16. Application One

Figure 17. Application Two

Figure 18. Application Three

Figure 19. Application Four

Figure 20. Application Five

Figure 21. Application Six

Figure 22. Application Seven

Figure 23. Application Eight

Figure 24. Application Nine

Figure 25. Global Oseltamivir Intermediate Production Value (US$ Million), 2020 VS 2024 VS 2031

Figure 26. Global Oseltamivir Intermediate Production Value (US$ Million) & (2020-2031)

Figure 27. Global Oseltamivir Intermediate Production Capacity (Tons) & (2020-2031)

Figure 28. Global Oseltamivir Intermediate Production (Tons) & (2020-2031)

Figure 29. Global Oseltamivir Intermediate Average Price (US$/kg) & (2020-2031)

Figure 30. Oseltamivir Intermediate Report Years Considered

Figure 31. Oseltamivir Intermediate Production Share by Manufacturers in 2024

Figure 32. Global Oseltamivir Intermediate Production Value Share by Manufacturers (2024)

Figure 33. Oseltamivir Intermediate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 34. The Global 5 and 10 Largest Players: Market Share by Oseltamivir Intermediate Revenue in 2024

Figure 35. Global Oseltamivir Intermediate Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 36. Global Oseltamivir Intermediate Production Value Market Share by Region: 2020 VS 2024 VS 2031

Figure 37. Global Oseltamivir Intermediate Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)

Figure 38. Global Oseltamivir Intermediate Production Market Share by Region: 2020 VS 2024 VS 2031

Figure 39. North America Oseltamivir Intermediate Production Value (US$ Million) Growth Rate (2020-2031)

Figure 40. Europe Oseltamivir Intermediate Production Value (US$ Million) Growth Rate (2020-2031)

Figure 41. China Oseltamivir Intermediate Production Value (US$ Million) Growth Rate (2020-2031)

Figure 42. Japan Oseltamivir Intermediate Production Value (US$ Million) Growth Rate (2020-2031)

Figure 43. India Oseltamivir Intermediate Production Value (US$ Million) Growth Rate (2020-2031)

Figure 44. Southeast Asia Oseltamivir Intermediate Production Value (US$ Million) Growth Rate (2020-2031)

Figure 45. Global Oseltamivir Intermediate Consumption by Region: 2020 VS 2024 VS 2031 (Tons)

Figure 46. Global Oseltamivir Intermediate Consumption Market Share by Region: 2020 VS 2024 VS 2031

Figure 47. North America Oseltamivir Intermediate Consumption and Growth Rate (2020-2031) & (Tons)

Figure 48. North America Oseltamivir Intermediate Consumption Market Share by Country (2020-2031)

Figure 49. U.S. Oseltamivir Intermediate Consumption and Growth Rate (2020-2031) & (Tons)

Figure 50. Canada Oseltamivir Intermediate Consumption and Growth Rate (2020-2031) & (Tons)

Figure 51. Europe Oseltamivir Intermediate Consumption and Growth Rate (2020-2031) & (Tons)

Figure 52. Europe Oseltamivir Intermediate Consumption Market Share by Country (2020-2031)

Figure 53. Germany Oseltamivir Intermediate Consumption and Growth Rate (2020-2031) & (Tons)

Figure 54. France Oseltamivir Intermediate Consumption and Growth Rate (2020-2031) & (Tons)

Figure 55. U.K. Oseltamivir Intermediate Consumption and Growth Rate (2020-2031) & (Tons)

Figure 56. Italy Oseltamivir Intermediate Consumption and Growth Rate (2020-2031) & (Tons)

Figure 57. Russia Oseltamivir Intermediate Consumption and Growth Rate (2020-2031) & (Tons)

Figure 58. Asia Pacific Oseltamivir Intermediate Consumption and Growth Rate (2020-2031) & (Tons)

Figure 59. Asia Pacific Oseltamivir Intermediate Consumption Market Share by Region (2020-2031)

Figure 60. China Oseltamivir Intermediate Consumption and Growth Rate (2020-2031) & (Tons)

Figure 61. Japan Oseltamivir Intermediate Consumption and Growth Rate (2020-2031) & (Tons)

Figure 62. South Korea Oseltamivir Intermediate Consumption and Growth Rate (2020-2031) & (Tons)

Figure 63. China Taiwan Oseltamivir Intermediate Consumption and Growth Rate (2020-2031) & (Tons)

Figure 64. Southeast Asia Oseltamivir Intermediate Consumption and Growth Rate (2020-2031) & (Tons)

Figure 65. India Oseltamivir Intermediate Consumption and Growth Rate (2020-2031) & (Tons)

Figure 66. Latin America, Middle East & Africa Oseltamivir Intermediate Consumption and Growth Rate (2020-2031) & (Tons)

Figure 67. Latin America, Middle East & Africa Oseltamivir Intermediate Consumption Market Share by Country (2020-2031)

Figure 68. Mexico Oseltamivir Intermediate Consumption and Growth Rate (2020-2031) & (Tons)

Figure 69. Brazil Oseltamivir Intermediate Consumption and Growth Rate (2020-2031) & (Tons)

Figure 70. Turkey Oseltamivir Intermediate Consumption and Growth Rate (2020-2031) & (Tons)

Figure 71. GCC Countries Oseltamivir Intermediate Consumption and Growth Rate (2020-2031) & (Tons)

Figure 72. Global Production Market Share of Oseltamivir Intermediate by Type (2020-2031)

Figure 73. Global Production Value Market Share of Oseltamivir Intermediate by Type (2020-2031)

Figure 74. Global Oseltamivir Intermediate Price (US$/kg) by Type (2020-2031)

Figure 75. Global Production Market Share of Oseltamivir Intermediate by Application (2020-2031)

Figure 76. Global Production Value Market Share of Oseltamivir Intermediate by Application (2020-2031)

Figure 77. Global Oseltamivir Intermediate Price (US$/kg) by Application (2020-2031)

Figure 78. Oseltamivir Intermediate Value Chain

Figure 79. Channels of Distribution (Direct Vs Distribution)

Figure 80. Bottom-up and Top-down Approaches for This Report

Figure 81. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6Q20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35Z19949

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26E19785

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions